GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹14 Cr | ₹18 Cr | ₹9.42 Cr | ₹11 Cr | ₹7.66 Cr |
What is the latest Sundry Debtors ratio of GENNEX LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹9.42 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹7.66 Cr |
How is Sundry Debtors of GENNEX LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | -20.49 | |
| Mar2024 | ₹18 Cr | 89.14 | |
| Mar2023 | ₹9.42 Cr | -16.76 | |
| Mar2022 | ₹11 Cr | 47.75 | |
| Mar2021 | ₹7.66 Cr | - | |
Compare Sundry Debtors of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹242.2 Cr | -1.7% | -16% | -13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -1.7% |
-16% |
-13.4% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses